Published in Experientia on June 15, 1989
Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33
Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity (2009) 2.05
Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics (2009) 2.03
Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth. Cancer Res (2012) 1.84
Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci U S A (1990) 1.25
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem J (1997) 1.24
Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol (2005) 1.17
Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown. BMC Physiol (2001) 0.99
Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect Immun (1994) 0.97
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. Redox Rep (2010) 0.96
Diminished quality of life in patients with cancer correlates with tryptophan degradation. J Cancer Res Clin Oncol (2007) 0.95
Th1 cytokines are essential for placental immunity to Listeria monocytogenes. Infect Immun (2005) 0.91
Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function. J Gen Virol (2009) 0.86
Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci. J Bacteriol (2012) 0.85
Lens epithelial cell apoptosis and intracellular Ca2+ increase in the presence of xanthurenic acid. BMC Ophthalmol (2002) 0.85
In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther (2013) 0.85
Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. Biochem J (2005) 0.85
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. Cancer Immunol Res (2015) 0.84
IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells. J Immunol (2011) 0.82
Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse. J Biol Chem (2012) 0.80
Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells. Infect Immun (1991) 0.80
Xanthurenic acid translocates proapoptotic Bcl-2 family proteins into mitochondria and impairs mitochondrial function. BMC Cell Biol (2004) 0.79
Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia. Mucosal Immunol (2017) 0.76
The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy. J Biomed Sci (2014) 0.75
Efficacy of an immune modulator in experimental Chlamydia trachomatis infection of the female genital tract. Infect Dis Obstet Gynecol (2006) 0.75
Tumor growth control with IDO-silencing Salmonella--reply. Cancer Res (2013) 0.75
Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology (2017) 0.75
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev (1994) 4.94
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28
Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun (1978) 4.26
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis (2003) 3.73
Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun (1997) 3.12
Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells). Infect Immun (1976) 3.11
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun (1999) 3.03
Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect Immun (1983) 2.77
Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells). Infect Immun (1976) 2.76
The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65
Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls. Infect Immun (1982) 2.58
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun (1994) 2.58
A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55
Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol (1994) 2.54
Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (1997) 2.51
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages. J Immunol (1982) 2.40
Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun (1988) 2.30
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ (2004) 2.17
Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect Immun (1983) 2.17
Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med (1980) 2.07
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98
Kinetics of phagocytosis of Chlamydia psittaci by mouse fibroblasts (L cells): separation of the attachment and ingestion stages. Infect Immun (1978) 1.94
Lymphokine enhances oxygen-independent activity against intracellular pathogens. J Exp Med (1983) 1.93
Arthropathic properties of cell wall polymers from normal flora bacteria. Infect Immun (1986) 1.88
Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res (1987) 1.87
Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis (1999) 1.79
Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res (2001) 1.79
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res (1989) 1.74
Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res (2001) 1.73
Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J Interferon Res (1986) 1.70
Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun (1987) 1.69
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol (1987) 1.65
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A (1996) 1.56
Specialization in veterinary medicine: where we've been and where we're going. J Am Vet Med Assoc (1990) 1.55
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54
Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun (1995) 1.54
IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol (1993) 1.53
Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation. Infect Immun (1983) 1.53
The Fate of Micrococcus Aureus introduced into the Blood Stream of Dogs. J Med Res (1917) 1.52
Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae. Microbes Infect (1999) 1.52
Concepts of fever: recent advances and lingering dogma. Clin Infect Dis (1997) 1.50
Cytochalasin B does not inhibit ingestion of Chlamydia psittaci by mouse fibroblasts (L cells) and mouse peritoneal macrophages. Infect Immun (1979) 1.48
T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol (1996) 1.48
A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47
Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis (1998) 1.46
Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril (2001) 1.44
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood (2000) 1.44
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun (1991) 1.42
Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. J Clin Microbiol (1980) 1.42
Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol (1989) 1.41
Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect Immun (1994) 1.41
Utility of duplex Doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr (1995) 1.40
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1989) 1.38
Traumatic musculotendinous injuries of the knee: diagnosis with MR imaging. Radiographics (2000) 1.38
Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (1994) 1.37
[Bladder instillation of adriamycin in the treatment of bladder tumors. Report 1: Clinical results (author's transl)]. Nihon Hinyokika Gakkai Zasshi (1977) 1.36
Studies on the structure of water using two-dimensional near-infrared correlation spectroscopy and principal component analysis. Anal Chem (2001) 1.35
The interferon refractory state: in vivo and in vitro studies of its mechanism. J Immunol (1971) 1.34
The water sensitive city: principles for practice. Water Sci Technol (2009) 1.31
IgE class-specific suppressor T cells and factors in humans. J Immunol (1983) 1.31
Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol (2004) 1.31
Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat (2001) 1.29
Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun (2001) 1.28
Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28
Arrays of hemispheric surface projections on Chlamydia psittaci and Chlamydia trachomatis observed by scanning electron microscopy. J Bacteriol (1979) 1.26
Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res (1982) 1.25
A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun (1998) 1.25
Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun (1999) 1.25
Generation of the topa quinone cofactor in bacterial monoamine oxidase by cupric ion-dependent autooxidation of a specific tyrosyl residue. FEBS Lett (1994) 1.24
Cell-mediated immune response during experimental arthritis induced in rats with streptococcal cell walls. Clin Exp Immunol (1980) 1.24
Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol (1999) 1.24
Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion (1995) 1.22
Amino acid sequence of a purothionin homolog from barley flour. J Biochem (1980) 1.21
Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab Disord (1965) 1.21
Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect Immun (1989) 1.20
A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans. J Clin Invest (1990) 1.20
Phenytoin-induced orofacial dyskinesia. A case report. J Neurol (1985) 1.19
Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost (2011) 1.18
Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer (1997) 1.18
Reactivation of chlamydial genital tract infection in mice. Infect Immun (1997) 1.17